INNOSPEC INC. (IOSP) Form 10-Q — Nov 4, 2026
Innospec reported Q3 2026 net sales of $473.6 million, up 7% year-over-year, with net income attributable to Innospec of $31.8 million ($1.29 diluted EPS) versus $12.9 million ($0.52) a year ago. The prior-year quarter was depressed by $42.0 million of property and intangible impairments, amplifying the optical growth rate. All three segments grew, led by Oilfield Services sales up 13% on the DRA plant expansion, while Performance Chemicals gross margin expanded 3.7 points on pricing improvements. Nine-month net sales rose 7% to $1,418.2 million.
Key figures
- Eps
- 1.29
- Revenue
- 473600000
- Net Income
- 31800000
- Revenue Yoy
- +7% (Q3); +7% nine months to $1,418.2M
- Cash Position
- 251900000
- Shares Outstanding
- 24631595
- Revolver capacity
- $250.0 million multicurrency revolving credit facility, undrawn, available until May 30, 2028
- Q3 2025 net income
- 12900000
- Q3 2025 eps diluted
- 0.52
- Q3 2025 impairments
- $22.9M PP&E and $19.1M intangibles (prior-year comparators)
- Effective tax rate q3
- 25.8%
- Nine month net income
- 93000000
- Nine month eps diluted
- 3.75
- Operating cash flow nine months
- 42200000
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.